
March 13 (Reuters) - Vivani Medical Inc VANI.O:
VIVANI MEDICAL ACHIEVES FIRST IMPLANT AND FULL ENROLLMENT IN THE FIRST-IN-HUMAN CLINICAL TRIAL OF GLP-1 IMPLANT NPM-115 IN OBESE OR OVERWEIGHT ADULTS
VIVANI MEDICAL INC: NPM-115 HAS SHOWED COMPARABLE PRECLINICAL WEIGHT LOSS TO INJECTIONS OF SEMAGLUTIDE
VIVANI MEDICAL INC - TOP-LINE STUDY RESULTS EXPECTED IN MID-2025